Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated No phase listed Observational

Avatrombopag for the Treatment of Thrombocytopenia in Adults With Chronic Liver Disease Undergoing a Procedure

ClinicalTrials.gov ID: NCT03554759

Public ClinicalTrials.gov record NCT03554759. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 30, 2026, 5:47 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Observational Cohort Study of the Use of Avatrombopag in Patients With Thrombocytopenia Associated With Chronic Liver Disease Undergoing a Procedure

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Phase 4 observational cohort study to characterize the treatment patterns and effects of avatrombopag use in patients with thrombocytopenia associated with chronic liver disease who are either undergoing, or have already undergone, a procedure.

Study identification

NCT ID
NCT03554759
Recruitment status
Terminated
Study type
Observational
Phase
Not listed
Lead sponsor
Sobi, Inc.
Industry
Enrollment
50 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Not listed

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 2, 2018 (Actual)
Primary completion
Jan 31, 2019 (Actual)
Completion
Jan 31, 2019 (Actual)
Last update posted
Oct 21, 2024

2018 – 2019

United States locations

U.S. sites
41
U.S. states
20
U.S. cities
40
Facility City State ZIP Site status
Dova Site Chandler Arizona 85224 —
Dova Site Lancaster California 93534 —
Dova Study Site Los Angeles California 90048 —
Dova Site Palm Springs California 92262 —
Dova Study Site Pasadena California 91107 —
Dova Study Site San Clemente California 92673 —
Dova Study Site San Diego California 92114 —
Dova Study Site San Diego California 92121 —
Dova Study Site Aurora Colorado 80045 —
Dova Study Site Englewood Colorado 80113 —
Dova Study Site Gainesville Florida 32610 —
Dova Study Site Miami Florida 33136 —
Dova Study Site Atlanta Georgia 30309 —
Dova Study Site Topeka Kansas 66606 —
Dova Study Site Louisville Kentucky 40202 —
Dova Study Site Baltimore Maryland 21202 —
Dova Study Site Boston Massachusetts 02215 —
Dova Study Site Burlington Massachusetts 01805 —
Dova Study Site Worcester Massachusetts 01655 —
Dova Study Site Ann Arbor Michigan 48109 —
Dova Study Site Detroit Michigan 48239 —
Dova Site Jackson Mississippi 39216 —
Dova Study Site New Brunswick New Jersey 08901 —
Dova Study Site Manhasset New York 11030 —
Dova Study Site New York New York 10016 —
Dova Study Site The Bronx New York 10467 —
Dova Study Site Durham North Carolina 27710 —
Dova Study Site Cleveland Ohio 44016 —
Dova Study Site Columbus Ohio 43210 —
Dova Study Site Flourtown Pennsylvania 19031 —
Dova Site Philadelphia Pennsylvania 19141 —
Dova Study Site Pittsburgh Pennsylvania 15213 —
Dova Study Site Johnson City Tennessee 37604 —
Dova Study Site Memphis Tennessee 38104 —
Dova Study Site Union City Tennessee 38261 —
Dova Study Site Dallas Texas 75234 —
Dova Study Site Houston Texas 77030 —
Dova Study Site Charlottesville Virginia 22908 —
Dova Study Site Richmond Virginia 23226 —
Dova Study SIte Roanoke Virginia 24014 —
Dova Study Site Milwaukee Wisconsin 53226 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03554759, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 21, 2024 · Synced Oct 30, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03554759 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →